Research map: SGLT2 inhibitor prescription at discharge in very old adults with heart failure irrespective of diabetes status

Back to the article

Papers in this map

  1. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation · Mary E. Charlson · 1987 · 50679 citations · Cited by this paper
  2. Mitigations for extra stimuli of the left ventricular endocardium with the WiSE-CRT System · 2026 · Related
  3. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure · Theresa A. McDonagh · 2021 · 13611 citations · Cited by this paper
  4. Heterogeneity of estrogen and β-adrenergic receptors in female human coronary artery endothelial cells · 2026 · Related
  5. STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. · Sidney Katz · 1963 · 12382 citations · Cited by this paper
  6. Peripheral microvascular function and long-term cardiovascular outcomes after percutaneous coronary intervention in patients with obstructive coronary artery disease · 2026 · Related
  7. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2007 · 10808 citations · Cited by this paper
  8. Add-on antiplatelet therapy in anticoagulated patients with atrial fibrillation · 2026 · Related
  9. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction · John J.V. McMurray · 2019 · 7146 citations · Cited by this paper
  10. One-year worsening heart failure and myocardial T1 mapping in patients with wild-type transthyretin amyloid cardiomyopathy undergoing tafamidis treatment · 2026 · Related
  11. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement · Eric I. Benchimol · 2015 · 5732 citations · Cited by this paper
  12. Diagnostic and prognostic value of T2 mapping in cardiac sarcoidosis · 2026 · Related
  13. Dapagliflozin in Patients with Chronic Kidney Disease · Hiddo J.L. Heerspink · 2020 · 5532 citations · Cited by this paper
  14. ‘A leukin to the future’: is low serum interleukin-2 (IL-2) a predictive biomarker for postoperative atrial fibrillation? · 2026 · Related
  15. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure · Milton Packer · 2020 · 5221 citations · Cited by this paper
  16. Persistent left superior vena cava is associated with complex atrial tachyarrhythmias in repaired tetralogy of Fallot: evidence for a right-sided arrhythmogenic substrate · 2026 · Related
  17. Empagliflozin in Heart Failure with a Preserved Ejection Fraction · Stefan D. Anker · 2021 · 4865 citations · Cited by this paper
  18. Low-dose ventricular radiotherapy in wild-type transthyretin cardiac amyloidosis: a prospective, first-in-human, exploratory clinical trial · 2026 · Related
  19. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction · Scott David Solomon · 2022 · 2871 citations · Cited by this paper
  20. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure · Theresa A. McDonagh · 2023 · 2438 citations · Cited by this paper
  21. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes · Nikolaus Marx · 2023 · 1602 citations · Cited by this paper
  22. Medical Therapy for Heart Failure With Reduced Ejection Fraction · Stephen John Greene · 2018 · 1323 citations · Cited by this paper
  23. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials · John G.F. Cleland · 2017 · 664 citations · Cited by this paper
  24. Nutritional status in older persons according to healthcare setting: A systematic review and meta-analysis of prevalence data using MNA ® · Emanuele Cereda · 2016 · 504 citations · Cited by this paper
  25. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · Paul A. Heidenreich · 2022 · 395 citations · Cited by this paper
  26. Heart Failure Association of the European Society of Cardiology Position Paper on Frailty in Patients with Heart Failure · Cristiana Vitale · 2019 · 265 citations · Cited by this paper
  27. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age · Felipe A. Martínez · 2019 · 210 citations · Cited by this paper
  28. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study ( US , UK and Sweden) · Gianluigi Savarese · 2021 · 170 citations · Cited by this paper
  29. Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial · Jawad H. Butt · 2022 · 162 citations · Cited by this paper
  30. Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial · Alexander Peikert · 2022 · 135 citations · Cited by this paper
  31. Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US · Jacob B. Pierce · 2023 · 115 citations · Cited by this paper
  32. Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age · Michael C Böhm · 2022 · 76 citations · Cited by this paper
  33. Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US · Khawaja Muhammad Talha · 2022 · 24 citations · Cited by this paper
  34. Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort · Luke R. Gagnon · 2024 · 11 citations · Cited by this paper
  35. Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registry · Giulia Ferrannini · 2026 · 5 citations · Cited by this paper
  36. Real-World Outcomes of SGLT2 Inhibitors in Very Elderly Patients With Heart Failure With Preserved Ejection Fraction · Abdelhakim Hacil · 2025 · 4 citations · Cited by this paper
  37. Clinical Effectiveness of Sodium‐Glucose Cotransporter‐2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction · Nicholas Keisuke Brownell · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)